Roadmap
We keep results, work in progress and plans separate. This page is updated every quarter.
Done
Things we have already achieved, with dates.
Up to 2025
- –2025FieldRan Seoul Day Care Center directly for five years and built up field data and operating experience
- 2024–ProductCompleted development of WellCare AI and began commercial operation
- 2024–2025ValidationPoC completed at 30 care facilities
- 2025.04.21FoundedSDC WellCare incorporated
- 2025IPPublic technology licensed (exclusive license)Hanbat National University Industry-Academic Cooperation Foundation
- 2025.11.05CertificationRegistered as a research institute company in Daedeok Innopolis (No. 2145)Ministry of Science and ICT
2026
- 2026.03.31CertificationCorporate R&D center recognized (No. 2026111241)Korea Industrial Technology Association (KOITA)
- 2026.05.20CertificationCertified as a venture company (No. 20260520010017)
- 2025–2026SelectionSelected for 14 government and public programs in Korea
Now
Work in progress in the second half of 2026, with the stage of each item.
- KoreaStatus: In progress
Nationwide field validation
Starting from the Daejeon area, we are expanding field validation at care facilities across Korea, with support from Daejeon Metropolitan City and Daejeon Technopark.
- KoreaStatus: In progress
Conversion to paid contracts
We are working with participating facilities so they can continue under paid contracts.
- KoreaStatus: Planned
Welfare centers and older adults at home
We are pursuing field validation with welfare centers and older adults living at home in the Daejeon area.
- ProductStatus: In development
WellCare Connect
We are defining the specification of a service that connects measuring devices with record systems. We are also preparing a second phase that supplies measuring devices with built-in Bluetooth.
- ValidationStatus: In progress
External performance validation
External performance validation (TTA, KAIC) is in progress.
- IPStatus: Done
Patent applications
In September 2026 we filed five patent applications related to AI analysis.
- JapanStatus: Planned
Preparing for Japan
We are preparing to set up a local company in Osaka. In parallel, we are preparing a consultation on whether the service is a medical device in Japan, applications to exhibit at local trade shows, and an application to an overseas branch support program.
Next
Plans for each area by year. Dates are targets, not results.
| Area | 2027 | 2028 | 2029–2030 |
|---|---|---|---|
| Korea | More paid contracts. Expansion from the Daejeon field validation to a Busan hub, then nationwide. Preparing to enter long-term care hospitals and home care | Nationwide expansion | A subscription-based business model in place |
| Product | Supplying measuring devices with built-in Bluetooth (second phase) so readings are saved automatically. API integration following file-based integration in WellCare Connect. Chronic-condition management features made official | Launch of a gait analysis service | Application to industrial safety |
| Certification, validation and IP | Publication of external performance validation results | Pursuing certification as AI software as a medical device (SaMD) | Wider certification scope |
| Overseas | January: start of field validation in Japan. Application for registration in Japan's welfare equipment information system (TAIS), response to Japan's care technology selection and subsidy channels, and local trade shows. Target of a first export to the United States | Joint sales with local partners in Japan | Expansion within Japan and into Southeast Asia |
Every cell is a plan. Items that depend on external review, such as certification and overseas registration, will be updated when results are out. Revenue plans and targets are not published on this page.
Overseas, we start with Japan
Japan is our first overseas market. Field validation there is planned to start in January 2027 (planned), and the Osaka subsidiary is in preparation. Other markets are at the exploration stage. A first export to the United States is a plan targeted for 2027.
Stage 1: Foundation
Prior consultation with the Association for Technical Aids, preparation of the Osaka subsidiary, WellCare Connect specification, contact with Japanese care software companies, partnership talks with device manufacturers, and prior consultation on medical device status.
Stage 2: Integration
Application for TAIS company and product registration, publication of a Japanese price list, completion of file-based integration and start of API integration, field validation at local facilities with baseline measurement.
Stage 3: Selection and expansion
Pursuing care technology selection, official API release, response to prefectural subsidy channels, and joint sales with local partners.
Research for the United States
- R&D · United StatesStatus: Planned
KidneyWatch AI
A research project on kidney and metabolic health management for the United States. A first export to the United States is a 2027 target.
About these plans
Plans may change depending on external review and the business environment.
This page is updated every quarter and when important events occur. The last update date is shown at the top of the page.
Need more information?
Revenue and funding plans are available in our IR materials. On the contact form, choose "Investment / IR" or "Partnership".